Literature

The expression level and prognostic value of HIPK3 among non-small-cell lung cancer patients in China


The expression level and prognostic value of HIPK3 among non-small-cell lung cancer patients in China.  (here)

Read More

Recent clinical trial findings are helping thoracic oncologists choose optimal immunotherapy treatments for their patients with NSCLC, but H. Borghaei stressed the importance of more effective biomarkers and sequencing criteria


Recent clinical trial findings are helping thoracic oncologists choose optimal immunotherapy treatments for their patients with non–small cell lung cancer…

Read More

Cases of potential transformation from NSCLC to SCLC during treatment with PD-1 inhibitors


Histologic transformation from non-small cell lung cancer (NSCLC) to small cell lung cancer (SCLC) is a well-recognized mechanism of resistance…

Read More

Activity of the Hsp90 inhibitor Luminespib among non-small cell lung cancers harboring EGFR exon 20 insertions


Activity of the Hsp90 inhibitor Luminespib among non-small cell lung cancers harboring EGFR exon 20 insertions.  (here)

Read More

Activity of the Hsp90 inhibitor Luminespib among non-small cell lung cancers harboring EGFR exon 20 insertions


Activity of the Hsp90 inhibitor Luminespib among non-small cell lung cancers harboring EGFR exon 20 insertions.  (here)

Read More

Characteristics, incidence, and risk factors of immune checkpoint inhibitor-related pneumonitis in patients with non-small cell lung cancer


Characteristics, incidence, and risk factors of immune checkpoint inhibitor-related pneumonitis in patients with non-small cell lung cancer  (here)

Read More